BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9449372)

  • 1. Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.
    Hall FL; Gordon EM; Wu L; Zhu NL; Skotzko MJ; Starnes VA; Anderson WF
    Hum Gene Ther; 1997 Dec; 8(18):2183-92. PubMed ID: 9449372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor.
    Hall FL; Liu L; Zhu NL; Stapfer M; Anderson WF; Beart RW; Gordon EM
    Hum Gene Ther; 2000 May; 11(7):983-93. PubMed ID: 10811227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
    Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
    Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
    Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
    J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction.
    Yajima T; Kanda T; Yoshiike K; Kitamura Y
    Hum Gene Ther; 1998 Apr; 9(6):779-87. PubMed ID: 9581901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
    Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
    J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1.
    Matano T; Odawara T; Iwamoto A; Yoshikura H
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3165-9. PubMed ID: 8847525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the putative receptor-binding domain of Moloney murine leukemia virus glycoprotein gp70.
    Panda BR; Kingsman SM; Kingsman AJ
    Virology; 2000 Jul; 273(1):90-100. PubMed ID: 10891411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
    Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
    Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.
    Masood R; Gordon EM; Whitley MD; Wu BW; Cannon P; Evans L; Anderson WF; Gill P; Hall FL
    Int J Mol Med; 2001 Oct; 8(4):335-43. PubMed ID: 11562769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.
    Liu L; Anderson WF; Beart RW; Gordon EM; Hall FL
    J Virol; 2000 Jun; 74(11):5320-8. PubMed ID: 10799609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
    Zavorotinskaya T; Albritton LM
    J Virol; 1999 Jul; 73(7):5621-9. PubMed ID: 10364311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interactions between monomers of the retroviral envelope protein complex.
    Zhao Y; Lee S; Anderson WF
    J Virol; 1997 Sep; 71(9):6967-72. PubMed ID: 9261425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
    Ragheb JA; Anderson WF
    J Virol; 1994 May; 68(5):3207-19. PubMed ID: 7512161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
    Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
    Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell targeting by murine recombinant retroviruses.
    Etienne-Julan M; Roux P; Bourquard P; Carillo S; Jeanteur P; Piechaczyk M
    Bone Marrow Transplant; 1992; 9 Suppl 1():139-42. PubMed ID: 1504656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion-targeted injectable vectors for vascular restenosis.
    Gordon EM; Zhu NL; Forney Prescott M; Chen ZH; Anderson WF; Hall FL
    Hum Gene Ther; 2001 Jul; 12(10):1277-87. PubMed ID: 11440621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of MoMuLV envelope protein on the cell surface.
    Yu H; Empig C; Xia J; Anderson WF
    Virology; 1998 Apr; 243(2):415-22. PubMed ID: 9568040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.